Finn Partners is working with the Africa Medical Supplies Platform, a non-profit initiative launched by the African Union in response to the COVID-19 pandemic.
The independent firm is supporting AMSP communication objectives in the UK, Europe and North America.
AMSP has received a commitment from The Bill and Melinda Gates Foundation to help secure nine million tablets of dexamethasone, a drug that has demonstrated reduction of mortality for COVID-19 patients in hospitals.
This agreement could benefit approximately one million people across Africa if they become hospitalized with COVID-related respiratory distress.
The drug will be distributed proportionately, without cost, across the continent. “This is yet another indicator of our commitment to communications around healthcare and the provision of services that help people live longer, healthier lives,” said Chantal Bowman-Boyles, Finn Partners' managing partner, Europe.
Finn Partners is O'Dwyer's No. 4 ranked firm with 2019 fees of $119.3M.